PDCD1 and myocarditis: Moslehi et al. describe 101 cases of severe myocarditis following immune checkpoint inhibitor treatment across various cancer types, with a higher frequency reported for the PD-1 and PDL-1/CTLA-4 combination with respect to monotherapy31.